Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Nutex Health Inc.NUTX · Entity 4803 | Director | July 31, 2026 | August 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Nutex Health Inc.
Report date July 31, 2026 · Filed August 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 670 |
Reported balance
After 2026-07-31 transaction · row 1
1 source rowRow 1 · 2026-07-31 · Exercise / conversion · Acquired 603 · Balance 670 F1: Restricted stock units convert into common stock on a one-for-one basis. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units convert into common stock on a one-for-one basis.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 31, 2026 Filed Aug 3, 2026 10:07 UTC | Nutex Health Inc. NUTX · Entity 4803 | Exercise / conversionCommon Stock | 603 | $0.00 | $0.00 |
DisclosureSEC source: 0001920511-26-000003 · primary_doc.xml · nonDerivative · entry 1 Grenas Cheryl Yvonne · CIK 0001920511 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 670 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| April 23, 2026 Filed Apr 24, 2026 18:21 UTC | Nutex Health Inc. NUTX · Entity 4803 | GrantRestricted Stock Units (RSUs) · Derivative | 823 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001920511-26-000002 · primary_doc.xml · derivative · entry 1 Grenas Cheryl Yvonne · CIK 0001920511 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,426 Underlying: Common Stock · 823 shares Expires 2027-04-23 F1 · derivative.exercise_price: Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting. F1 · shares: Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting. F1 · price: Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting. F2 · derivative.exercise_date: On April 23, 2026, the Reporting Person was granted 823 RSUs, which vest 100% on April 23, 2027. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company. F2 · derivative.expiration_date: On April 23, 2026, the Reporting Person was granted 823 RSUs, which vest 100% on April 23, 2027. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company. Read SEC document |
| July 14, 2025 Filed Feb 9, 2026 17:56 UTC | Nutex Health Inc. NUTX · Entity 4803 | GrantRestricted Stock Units (RSUs) · Derivative | 603 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001920511-26-000001 · primary_doc.xml · derivative · entry 1 Grenas Cheryl Yvonne · CIK 0001920511 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 603 Underlying: Common Stock · 603 shares Expires 2026-07-14 F1 · derivative.exercise_price: Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting. F1 · shares: Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting. F2 · derivative.exercise_date: On July 14, 2025, the Reporting Person was granted 603 RSUs, which vest 100% on July 14, 2026. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company. F2 · derivative.expiration_date: On July 14, 2025, the Reporting Person was granted 603 RSUs, which vest 100% on July 14, 2026. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company. Read SEC document |
| June 13, 2023 Filed Jun 16, 2023 11:46 UTC | Nutex Health Inc. NUTX · Entity 4803 | PurchaseCommon Stock | 10,000 | $0.43 | $4,300.00 |
DisclosureSEC source: 0001486189-23-000006 · primary_doc.xml · nonDerivative · entry 1 Grenas Cheryl Yvonne · CIK 0001920511 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See note(1) Disclosed balance after: 10,000 F1 · ownership.direct: Cheryl Grenas, a Director of the registrant is the indirect beneficial owner of 10,000 of the securities of the registrant reported herein of which Xavier Grenas, spouse of Cheryl Grenas is the direct owner. Read SEC document |
| May 09, 2022 Filed May 10, 2022 18:45 UTC | Nutex Health Inc. NUTX · Entity 4803 | GrantRestricted Stock Award | 19,280 | $3.89 | $74,999.20 |
DisclosureSEC source: 0001486189-22-000009 · primary_doc.xml · nonDerivative · entry 1 Grenas Cheryl Yvonne · CIK 0001920511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,280 F1 · shares: Vesting 1/12 on date of grant and 1/12 on the last day of each month beginning May 2022 through March 2023. Read SEC document |
| May 09, 2022 Filed Dec 30, 2022 20:43 UTC Amendment | Nutex Health Inc. NUTX · Entity 4803 | OtherRestricted Stock | 19,280 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001486189-22-000023 · primary_doc.xml · nonDerivative · entry 2 Grenas Cheryl Yvonne · CIK 0001920511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · date: The restricted stock award was voided ab initio and the reporting person returned the restricted stock subject to the May 9, 2022 award to the issuer for no consideration and the issuer cancelled such restricted stock. F1 · kind: The Amendment reports the rescission of the Restricted Stock Awards initially granted on May 9, 2022, as reported in the original Form 4. F2 · price: The restricted stock award was voided ab initio and the reporting person returned the restricted stock subject to the May 9, 2022 award to the issuer for no consideration and the issuer cancelled such restricted stock. Read SEC document |
| May 09, 2022 Filed Dec 30, 2022 20:43 UTC Amendment | Nutex Health Inc. NUTX · Entity 4803 | GrantRestricted Stock | 19,280 | $3.89 | $74,999.20 |
DisclosureSEC source: 0001486189-22-000023 · primary_doc.xml · nonDerivative · entry 1 Grenas Cheryl Yvonne · CIK 0001920511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,280 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.